Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,2865,330,82
Msft-0,71
Nokia3,373,5035-5,96
IBM-1,19
Mercedes-Benz Group AG64,5664,571,66
PFE-1,07
19.07.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 18.07.2024 21:59:41
Nu Skin Enter (NUS, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
10,72 -2,10 -0,23 387 876
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.07.2024
Popis společnosti
Obecné informace
Název společnostiNu Skin Enterprises, Inc.
TickerNUS
TickerNUS.B
Kmenové akcie:Ordinary Shares Class A
Kmenové akcie:Ordinary Shares
RICNUS.B
RICNUS
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 3 700
Akcie v oběhu k 01.05.2024 49 667 403
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
UliceATTN: D. MATTHEW DORNY
MěstoPROVO
PSČ84601
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 013 456 100
Fax18013455999

Business Summary: Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Nu Skin Enterprises, Inc. revenues decreased 13% to $417.3M. Net loss totaled $533K vs. income of $11.4M. Revenues reflect Nu Skin segment decrease of 20% to $354.8M, South Korea segment decrease of 42% to $41M, America/Pacific segment decrease of 26% to $75M. Dividend per share decreased from $0.39 to $0.06. Basic Earnings per Share excluding Extraordinary Items decreased from $0.23 to -$0.01.
Odvětvová klasifikace
TRBC2009Personal Products
TRBC2012Personal Products (NEC)
RBSS2004Personal Products
MGINDUSTRYMajor Drugs
MGSECTORHealthcare
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSToilet Preparation Manufacturing
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Toilet Preparation Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICS1997Toilet Preparation Manufacturing
SICDrugs/proprietaries/sundries
SICDrugs/proprietaries/sundries
SICToilet Preparations



  • Poslední aktualizace: 19.07.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardSteven Lund7001.01.1996
President, Chief Executive Officer, DirectorRyan Napierski5001.09.202108.09.2015
Chief Financial Officer, Executive Vice PresidentJames Thomas4524.07.202331.03.2023
Executive Vice President, General CounselChayce Clark4101.08.202101.08.2021
Executive Vice President - Product DevelopmentJoseph Chang7130.03.2024
Executive Vice President, Chief Product OfficerSteven Hatchett52